Posted on 7/27/18
Boston Beer (SAM) Q2 2018 Results - Earnings Call Transcript
Boston Beer Co., Inc. (NYSE:SAM) Q2 2018 Earnings Call July 26, 2018 5:00 PM ETExecutivesC. James Koch - Boston Beer Co., Inc.David A. Burwick - Boston . . .
Posted on 7/26/18
Benchworks Launches Health System Marketing
Benchworks is pleased to announce it has launched a new division, Health System Marketing to help hospitals, health systems and providers enhance their branding and revenue . . .
Posted on 7/26/18
Implanet Opens German Subsidiary
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Implanet (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans; OTCQX: IMPZY), a medical technology company specializing in vertebral . . .
Posted on 7/26/18
Genprex Enters Agreement with the University of Texas MD Anderson Cancer Center
AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary . . .
Posted on 7/26/18
Tenable Prices IPO at $23.00 Per Share
Tenable Holdings, Inc. today announced the pricing of its initial public offering of 10,900,000shares of common stock at a price to the public of $23.00 per . . .
Posted on 7/26/18
Thermo Fisher Scientific (TMO) Q2 2018 Results - Earnings Call Transcript
Thermo Fisher Scientific, Inc. (NYSE:TMO) Q2 2018 Earnings Call July 25, 2018 8:30 AM ETExecutivesKenneth J. Apicerno - Thermo Fisher Scientific, Inc.Marc N. Casper - Thermo . . .
Posted on 7/26/18
Boston Scientific (BSX) Q2 2018 Results - Earnings Call Transcript
Boston Scientific Corp. (NYSE:BSX) Q2 2018 Earnings Call July 25, 2018 8:00 AM ETExecutivesSusan Vissers Lisa - Boston Scientific Corp.Michael F. Mahoney - Boston Scientific Corp.Daniel . . .
Posted on 7/26/18
Biogen Posts Solid Earnings as the Biotech Waits for Clinical Trial Data
Biogen (NASDAQ:BIIB) reported solid second-quarter earnings on Tuesday, buoyed by a doubling in sales of its spinal muscular atrophy drug Spinraza, which was developed with Ionis . . .
Posted on 7/25/18
EG Life Sciences Expands Services to Include Biometrics
EG Life Sciences announced today that Eliassen Group's existing Biometrics and Data Solutions is to be repositioned under the EG Life Sciences umbrella of service offerings. . . .
Posted on 7/25/18
Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities
Carilion Clinic, a not-for-profit healthcare organization serving nearly one million residents in western Virginia, has joined the TriNetX global health research network to better assess its . . .
Posted on 7/25/18
Thermo Fisher Scientific Reports Second Quarter 2018 Results
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 30, 2018.Second Quarter . . .
Posted on 7/25/18
Provident Healthcare Partners Advises Dermatology And Surgery Associates In Its Partnership With BelHealth Investment Partners
Dermatology and Surgery Associates, a leading provider of general, cosmetic, and surgical dermatology services based in East Bronx, New York, has completed a recapitalization with BelHealth . . .
Posted on 7/25/18
Seniorlink Wins 2018 Caregiver Friendly Award From Today's Caregiver Magazine
Seniorlink, Inc., a tech-enabled health services company transforming care management in the home, received the 2018 Caregiver Friendly Award from Today's Caregiver magazine. The award recognized . . .
Posted on 7/25/18
Finch Therapeutics Expands Its Leading Microbiome IP Estate with Six New Patents
SOMERVILLE, Mass.--(BUSINESS WIRE)--Finch Therapeutics Group, Inc. (Finch), a clinical-stage microbiome therapeutics company, announced today that the U.S. Patent and Trademark Office (USPTO) has issued six new . . .
Posted on 7/25/18
BSX: Boston Scientific Corporation SEC Filing - Current report (8-K) July 25, 2018
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following . . .
Posted on 7/25/18
Vertex Pharmaceuticals: Opportunities And Dangers
SummaryVertex has a high P/E ratio of 214, so is priced to perfection.Vertex saw a big dip in 2016 after Incivek revenue dropped.Successful expansion in and . . .
Posted on 7/25/18
Biogen Inc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Biogen Inc. in conjunction with their 2018 Q2 earnings call. 139READ FULL ARTICLE HERE
Posted on 7/25/18
Biogen, Inc. (BIIB) CEO Michel Vounatsos on Q2 2018 Results - Earnings Call Transcript
Biogen, Inc. (NASDAQ:BIIB) Q2 2018 Earnings Conference Call July 24, 2018 8:00 AM ETExecutivesMatt Calistri - Vice President, Investor RelationsMichel Vounatsos - Chief Executive OfficerMichael Ehlers . . .
Posted on 7/25/18
bluebird bio Prices Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced the pricing of an underwritten public offering of 3,384,616 shares of its common stock at a public . . .
Posted on 7/24/18
Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced it has entered into . . .
Posted on 7/23/18
Bone Biologics Completes $5.9 Million of Financing
Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets
Posted on 7/23/18
Lysogene Reports Second Quarter Cash Position and Provides Business and Strategic Update
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Regulatory News:Lysogene (FR0013233475 – LYS) (Paris:LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, today reports . . .
Posted on 7/23/18
Sanofi Ventures Leads $17 Million Financing of Click Therapeutics
Click Therapeutics, Inc. a leader in Digital Therapeutics solutions as prescription medical treatments, announces a $17 million financing round led by Sanofi Ventures.
Posted on 7/22/18
PureTech Health Announces Collaboration with Roche
BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC), a clinical-stage biopharmaceutical company developing novel medicines focused on the Brain-Immune-Gut (BIG) Axis, today announced that it has entered into . . .
Posted on 7/22/18
LaVoieHealthScience Adds XenoTherapeutics to Client Roster
BOSTON--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced the addition of XenoTherapeutics to its client . . .

